Gene · 773
NIH grants2,357
NIH grants whose papers are about the gene, through NIH's grant-paper links.
181 to 200 of 2,357
Download this page as JSON| Grant | Title | CACNA1A papers | Newest fiscal year |
|---|---|---|---|
| R01DK073368 | Mechanisms of Compartmentalized cAMP Signaling | 1 | 2025 |
| R01DK090570 | Defining the role of MafA in islet beta cells | 1 | 2025 |
| R01DK110276 | Paracrine feedback by pancreatic delta cells to control glucagon and insulin release and manage diabetes | 1 | 2025 |
| R01DK113185 | Comprehensive characterization of HNF1A-driven beta-cell heterogeneity | 1 | 2025 |
| R01DK119482 | Role of Urothelial Purinergic Signaling in Diabetic Bladder Dysfunction | 1 | 2025 |
| R01DK120759 | Role of interstitial cells of Cajal in patterned colonic motor activity | 1 | 2025 |
| R01DK131437 | Understanding the variation of induced β-cell differentiation. | 1 | 2025 |
| R01DK134575 | A genomics-based strategy to precision phenotyping and drug repositioning in cardiometabolic diseases | 1 | 2025 |
| R01DK138834 | Targeting visceral pain through intestinal neuropod cell GUCY2C signaling | 1 | 2025 |
| R01EY012601 | Hematopoietic cell mobilization from distinct bone marrow compartments following retinal injury | 1 | 2025 |
| R01EY017017 | Dietary control of angiogenesis in retinopathy models | 1 | 2025 |
| R01EY018213 | Defining Barriers to Gene Therapy | 1 | 2025 |
| R01EY020894 | Targeting Tissue Biomechanics for Treatment of Glaucoma | 1 | 2025 |
| R01EY024963 | RORalpha mediates chronic subretinal inflammation associated with AMD | 1 | 2025 |
| R01EY029342 | Kinase Multitargeting for Glaucoma Neuroprotection | 1 | 2025 |
| R01EY035679 | Foundational Biology of Glaucoma GWAS Loci | 1 | 2025 |
| R01GM085115 | Mechanisms that control neuronal microtubule polarity | 1 | 2025 |
| R01GM113230 | Functional evolution of segmentation gene regulatory networks in insects | 1 | 2025 |
| R01GM121907 | Genomic basis of phenotypic variability of complex disorders | 1 | 2025 |
| R01GM124320 | Target specificity of human RNA-induced silencing complex | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/773/grants?page=10